Cannabis Bioscience International Holdings (CBIH) Revenue (2022 - 2026)

Cannabis Bioscience International Holdings has disclosed Revenue across 5 years of filings, most recently posting $11205.0 for Q1 2026.

• Revenue for Q1 2026 came in at $11205.0, down 24.95% year-over-year; the trailing twelve-month figure through Feb 2026 was $123627.0 (down 64.05% YoY), and the FY2025 annual result was $303022.0, up 21.77% from the prior year.
• Revenue came in at $11205.0 for Q1 2026 at Cannabis Bioscience International Holdings, down from $53266.0 in the prior quarter.
• In the past five years, Revenue ranged from a high of $178887.0 in Q3 2024 to a low of $11205.0 in Q1 2026.
• The 5-year median for Revenue is $52259.0 (2023), against an average of $58627.1.
• Across the five-year window, Revenue surged 145.65% in 2024 and plunged 86.47% in 2025, its largest moves.
• Cannabis Bioscience International Holdings' Revenue stood at $82581.0 in 2022, then slipped by 22.81% to $63748.0 in 2023, then grew by 16.47% to $74248.0 in 2024, then slipped by 28.26% to $53266.0 in 2025, then slumped by 78.96% to $11205.0 in 2026.
• The last three Revenue figures came in at $11205.0 (Q1 2026), $53266.0 (Q4 2025), and $24200.0 (Q3 2025), per Business Quant data.